miR-378a: a new emerging microRNA in metabolism.
Ivo F MachadoJoão S TeodoroCarlos M PalmeiraAnabela P RoloPublished in: Cellular and molecular life sciences : CMLS (2019)
Metabolic diseases, such as type 2 diabetes or obesity, are the consequence of the disruption of the organism's metabolic pathways. The discovery of small non-coding RNAs-microRNAs (miRNAs)-as post-transcriptional gene regulators opened new doors for the development of novel strategies to combat said diseases. The two strands of miR-378a, miR-378a-3p, and miR-378a-5p are encoded in the Ppargc1b gene and have an active role in the regulation of several metabolic pathways such as mitochondrial metabolism and autophagy. Recent studies recognized miR-378a as an important regulator of energy and glucose homeostasis, highlighting it as a potential target for the improvement of metabolic dysregulation. In the present review, the current knowledge on miR-378a will be discussed with a particular emphasis on its biological functions and mechanisms of action in metabolism, mitochondria, and autophagy.
Keyphrases
- cell proliferation
- long non coding rna
- type diabetes
- long noncoding rna
- cell death
- oxidative stress
- transcription factor
- healthcare
- endoplasmic reticulum stress
- metabolic syndrome
- cardiovascular disease
- insulin resistance
- genome wide
- copy number
- weight loss
- gene expression
- small molecule
- blood pressure
- weight gain
- genome wide identification
- body mass index
- blood glucose
- glycemic control
- high fat diet induced
- endoplasmic reticulum
- heat shock
- reactive oxygen species